Antitrust scrutiny of healthcare markets is nothing new. The Biden Administration and first Trump Administration focused antitrust enforcement efforts across the healthcare and life sciences industries. The newly installed...more
5/27/2025
/ Acquisitions ,
Antitrust Division ,
Antitrust Provisions ,
Chile ,
Competition ,
Corporate Practice of Medicine ,
Department of Justice (DOJ) ,
Deregulation ,
Enforcement Actions ,
EU ,
Healthcare ,
Healthcare Workers ,
Life Sciences ,
Mergers ,
Partnerships ,
Patents ,
Pharmaceutical Patents ,
South Africa ,
State Attorneys General ,
Teva Pharmaceuticals ,
Trump Administration
The Department of Justice Antitrust Division (DOJ) recently withdrew three sets of policy statements regarding the US antitrust agencies’ enforcement approach to conduct in the healthcare industry. These policy statements...more
On June 3, 2022, Department of Justice Antitrust Division Deputy Assistant General Richard A. Powers reiterated the Division’s intent to bring more cases to trial and touted the Division’s record number of open...more
In recent years, both Republican and Democratic-led antitrust agencies have pursued aggressive merger enforcement programs, litigating many cases and settling many more. However, “populist” and other progressive critics have...more